Movement Alert｜Qingsong Health Rises 13.24% in Regular Trading, Global AI Trustworthy Narrative Fuels Medical AI Rebound

Market Focus

Yesterday

On June 5, Qingsong Health (02661.HK) rose 13.24% in regular trading, trading at HKD 24.82/share, with trading volume of HKD 169 million, significantly higher than its recent daily average.

On the news front, the global trustworthy AI narrative continues to intensify. Anthropic recently completed a USD 65 billion funding round at a USD 965 billion valuation, with honesty as its core model upgrade direction, signaling strong capital endorsement of enterprise-grade trustworthy AI. The Hong Kong AI application sector saw elevated sentiment, with Zhipu accumulating over 60% gains recently, as capital accelerated into AI commercialization plays.

Meanwhile, the company recently announced a strategic partnership with premium general practice brand Yi He Ni, embedding its proprietary evidence-based medical agent into high-net-worth health management scenarios. As the first domestic AI medical product to pass the CAICT MedClaw evaluation, Qingsong Health benefits from sector linkage and policy tailwinds, with capital reflowing to drive the rebound from prior lows.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1175635822"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1175635822\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1175635822?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 09:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1175635822","market":"us","top_or_hot":-1,"title":"Movement Alert｜Qingsong Health Rises 13.24% in Regular Trading, Global AI Trustworthy Narrative Fuels Medical AI Rebound","media":"Market Focus","content":"<p><p>On June 5, Qingsong Health (02661.HK) rose 13.24% in regular trading, trading at HKD 24.82/share, with trading volume of HKD 169 million, significantly higher than its recent daily average.</p><p>On the news front, the global trustworthy AI narrative continues to intensify. Anthropic recently completed a USD 65 billion funding round at a USD 965 billion valuation, with honesty as its core model upgrade direction, signaling strong capital endorsement of enterprise-grade trustworthy AI. The Hong Kong AI application sector saw elevated sentiment, with Zhipu accumulating over 60% gains recently, as capital accelerated into AI commercialization plays.</p><p>Meanwhile, the company recently announced a strategic partnership with premium general practice brand Yi He Ni, embedding its proprietary evidence-based medical agent into high-net-worth health management scenarios. As the first domestic AI medical product to pass the CAICT MedClaw evaluation, Qingsong Health benefits from sector linkage and policy tailwinds, with capital reflowing to drive the rebound from prior lows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Qingsong Health Rises 13.24% in Regular Trading, Global AI Trustworthy Narrative Fuels Medical AI Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Qingsong Health Rises 13.24% in Regular Trading, Global AI Trustworthy Narrative Fuels Medical AI Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-05 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 5, Qingsong Health (02661.HK) rose 13.24% in regular trading, trading at HKD 24.82/share, with trading volume of HKD 169 million, significantly higher than its recent daily average.</p><p>On the news front, the global trustworthy AI narrative continues to intensify. Anthropic recently completed a USD 65 billion funding round at a USD 965 billion valuation, with honesty as its core model upgrade direction, signaling strong capital endorsement of enterprise-grade trustworthy AI. The Hong Kong AI application sector saw elevated sentiment, with Zhipu accumulating over 60% gains recently, as capital accelerated into AI commercialization plays.</p><p>Meanwhile, the company recently announced a strategic partnership with premium general practice brand Yi He Ni, embedding its proprietary evidence-based medical agent into high-net-worth health management scenarios. As the first domestic AI medical product to pass the CAICT MedClaw evaluation, Qingsong Health benefits from sector linkage and policy tailwinds, with capital reflowing to drive the rebound from prior lows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02661","symbol_name":"轻松健康","start_time":0,"source_url":"","article_id":"1175635822","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1175635822","pubTimestamp":1780623744,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 5, Qingsong Health (02661.HK) rose 13.24% in regular trading, trading at HKD 24.82/share, with trading volume of HKD 169 million, significantly higher than its recent daily average.On the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02661":"轻松健康"},"translate_title":"动感快讯|青松健康常规交易涨13.24%全球AI可信叙事助推医疗AI反弹","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02661":1},"content_text":"On June 5, Qingsong Health (02661.HK) rose 13.24% in regular trading, trading at HKD 24.82/share, with trading volume of HKD 169 million, significantly higher than its recent daily average.On the news front, the global trustworthy AI narrative continues to intensify. Anthropic recently completed a USD 65 billion funding round at a USD 965 billion valuation, with honesty as its core model upgrade direction, signaling strong capital endorsement of enterprise-grade trustworthy AI. The Hong Kong AI application sector saw elevated sentiment, with Zhipu accumulating over 60% gains recently, as capital accelerated into AI commercialization plays.Meanwhile, the company recently announced a strategic partnership with premium general practice brand Yi He Ni, embedding its proprietary evidence-based medical agent into high-net-worth health management scenarios. As the first domestic AI medical product to pass the CAICT MedClaw evaluation, Qingsong Health benefits from sector linkage and policy tailwinds, with capital reflowing to drive the rebound from prior lows.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}